Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria
Aims To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volunteers and patients with symptomatic falciparum malaria. Methods Healthy volunteer data were obtained from six volunteers who received three different doses of HF (250, 500 and 1000 mg) after an...
Asıl Yazarlar: | Klein, K, Aarons, L, Ter Kuile, F, Nosten, F, White, N, Edstein, MD, Teja-Isavadharm, P |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2012
|
Benzer Materyaller
-
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria.
Yazar:: Klein, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
Yazar:: Krishna, S, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
Yazar:: ter Kuile, F, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography.
Yazar:: Ter Kuile, F, ve diğerleri
Baskı/Yayın Bilgisi: (1994) -
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
Yazar:: Simpson, J, ve diğerleri
Baskı/Yayın Bilgisi: (1999)